Delivery Order SPE2DB22D1106-SPE2DB24FFGW1

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,436.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of PHENOBARBITAL 65 MG/ML VIAL. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp, with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,924.30, is for the delivery of PHENOBARBITAL 65 MG/ML VIALML. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of August 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award (SPE2DX15D3006|SPE2DX25F01WP) issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,190.18 firm fixed-price delivery order is for the supply of 4567090412 - PHENOBARBITAL 130 MG/ML VIALML, with a performance period ending on January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 130 mg/ml vials of the pharmaceutical product Phenobarbital. The $3,172.24 contract has a performance period through February 12, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,436.32 contract is for the delivery of Phenobarbital 65 mg/ml vials, a medication used for various medical conditions. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,006.47 firm fixed price delivery order is for the supply of 4565012904 Phenobarbital 65 mg/mL vials. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This is a $1,241.12 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565084123 - Phenobarbital 65 mg/ml vial, a pharmaceutical product used in medical treatment. The award is not associated with a set-aside program, and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to provide a...
This federal contract award, valued at $2,117.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Phenobarbital 130 mg/ml vials and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $2,705.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,284,280 milliliters of 130 mg/mL Phenobarbital vials. This is a Firm Fixed Price Delivery Order contract with a completion date of July 30, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,353.29, is for the delivery of Phenobarbital 65 mg/ml vial. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFGW1
    Delivery Order

This is a $10,254.64 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565468605 PHENOBARBITAL 130 MG/ML VIALML, with a period of performance through August 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, for providing a wide range of medical commodities to support military treatment programs and other government healthcare needs. This contract does not have a set-aside designation.

Generated 11/14/24, 9:17 AM